Association between ALT/AST and Muscle Mass in Patients with Type 2 Diabetes Mellitus

Table 3

The correlation between SMI and clinical characteristics.

	Male		Female
	β (95% CI)	value	β (95% CI)	value
Age (years)	-0.021 (-0.029, -0.013)	<0.001	-0.024 (-0.033, -0.015)	<0.001
Duration (years)	-0.002 (-0.017, 0.013)	0.784	0.005 (-0.009, 0.019)	0.475
SBP (mmHg)	0.004 (-0.001, 0.010)	0.094	0.006 (0.000, 0.011)	0.031
DBP (mmHg)	0.005 (-0.003, 0.013)	0.197	-0.001 (-0.010, 0.007)	0.754
ALT/AST	-0.270(-0.534,-0.006)	0.045	-0.396(-0.647,-0.146)	0.002
FPG (mmol/L)	0.024 (-0.010, 0.058)	0.164	-0.010 (-0.046, 0.026)	0.597
HbA1c (%)	-0.067 (-0.111, -0.023)	0.003	-0.016 (-0.065, 0.033)	0.520
TG (mmol/L)	0.016(-0.048, 0.080)	0.621	0.009 (-0.071, 0.088)	0.833
TC (mmol/L)	0.035(-0.255, 0.324)	0.814	0.028 (-0.175, 0.231)	0.787
LDL (mmol/L)	-0.015 (-0.307, 0.278)	0.921	-0.027 (-0.246, 0.192)	0.807
HDL (mmol/L)	-0.533 (-0.982, -0.084)	0.020	-0.266(-0.662, 0.131)	0.189